BOT 4.69% 33.5¢ botanix pharmaceuticals ltd

Clinical indications for this novel medicine will expand.Sweaty...

  1. 29 Posts.
    lightbulb Created with Sketch. 8
    Clinical indications for this novel medicine will expand.

    Sweaty hands, feet, legs, cholinergic urticaria, excess secretions, bronchospasm, colic, pupillary dilation, motion sickness etc

    Botanix market cap of $20B on the back of this clinically useful ultra-short acting anticholinergic.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
33.5¢
Change
0.015(4.69%)
Mkt cap ! $606.3M
Open High Low Value Volume
32.0¢ 34.0¢ 32.0¢ $1.459M 4.404M

Buyers (Bids)

No. Vol. Price($)
17 271241 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 243220 6
View Market Depth
Last trade - 15.06pm 09/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.